JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB4797

Anti-GSK3 (alpha + beta) (phospho Y216 + Y279) antibody

4

(4 Reviews)

|

(10 Publications)

Rabbit Polyclonal GSK3 alpha phospho Y216 antibody. Suitable for WB and reacts with Mouse samples. Cited in 10 publications. Immunogen corresponding to Synthetic Peptide within Mouse Glycogen synthase kinase-3 alpha.

View Alternative Names

Glycogen synthase kinase-3 alpha, GSK-3 alpha, Serine/threonine-protein kinase GSK3A, GSK3A, Glycogen synthase kinase-3 beta, GSK-3 beta, Serine/threonine-protein kinase GSK3B, GSK3B

1 Images
Western blot - Anti-GSK3 (alpha + beta) (phospho Y216 + Y279) antibody (AB4797)
  • WB

Supplier Data

Western blot - Anti-GSK3 (alpha + beta) (phospho Y216 + Y279) antibody (AB4797)

Extracts of 3T3L1 cells stimulated with 100 nM insulin for 10 minutes were resolved by SDS-PAGE on a 10% Tris-glycine gel and transferred to PVDF. The membrane was blocked with a 5% BSA-TBST buffer for one hour at room temperature and either left untreated (1-4) or treated with lambda (λ) phosphatase (5), then incubated with the GSK-3 α [pY279] / β [pY216] antibody for two hours at room temperature in a 1% BSATBST buffer, following its prior incubation with : the phosphopeptide immunogen (1), no peptide (2), the non-hosphopeptide corresponding to the phosphopeptide immunogen (3), or a generic phosphotyrosine-containing peptide (4). After washing, the membrane was incubated with goat F(ab') 2 anti-rabbit IgG HRP conjugate, and signals were detected. The data show that only the phosphopeptide corresponding to GSK-3α [pY279] /β[pY216] blocks the antibody signal, demonstrating the specificity of the antibody. The data also show that phosphatase stripping eliminates the signal, further verifying that the antibody is phospho-specific.

All lanes:

Western blot - Anti-GSK3 (alpha + beta) (phospho Y216 + Y279) antibody (ab4797)

Predicted band size: 47 kDa,51 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse

Applications

WB

applications

Immunogen

Synthetic Peptide within Mouse Glycogen synthase kinase-3 alpha. The exact immunogen used to generate this antibody is proprietary information.

Q2NL51

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.5-1 µg/mL", "WB-species-notes": "<p>Use at a concentration of 0.5 - 1.0 µg/ml. Predicted molecular weight: 51kDa for GSK 3 alpha and 47 kDa for GSK 3 beta.</p>" } } }

Product details

Glycogen synthase kinase-3 (GSK 3) is a proline-directed serine-threonine kinase that was initially identified as a phosphorylating and inactivating glycogen synthase. Two isoforms, alpha (GSK 3A) and beta, show a high degree of amino acid homology. GSK 3B is involved in energy metabolism, neuronal cell development, and body pattern formation.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
Purified from rabbit serum by epitope specific affinity chromatography. Any reactivity towards the non-tyrosine phosphorylated GSK 3 alpha + beta protein has been eliminated through a series of preabsorption steps.
Storage buffer
pH: 7.3 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The GSK3 protein known also as glycogen synthase kinase 3 has two isoforms: GSK3 alpha and GSK3 beta. Both isoforms have distinct yet significant mechanical roles. GSK3 alpha with a molecular weight of approximately 51 kDa and GSK3 beta weighing about 47 kDa act as serine/threonine kinases. These proteins are expressed in various tissues including the brain pancreas and liver. GSK3 is involved in the regulation of numerous cellular processes by phosphorylating its substrates impacting various cellular activities.
Biological function summary

GSK3 is integral in multiple signaling pathways and participates in the regulation of inflammation cell cycle and apoptosis. As part of the larger complex of signaling proteins GSK3 impacts the modulation of transcription factors and influences cellular differentiation and proliferation. The protein's kinase activity is necessary for maintaining cellular homeostasis and ensuring proper response to external signals.

Pathways

GSK3 influences critical pathways like Wnt and PI3K/Akt. Within the Wnt pathway GSK3 targets important proteins such as β-catenin where it plays an important role in controlling gene expression related to cell growth. In the PI3K/Akt pathway GSK3 acts as an important regulatory protein affecting insulin signaling and energy metabolism. Interactions with other kinases and transcription factors allow GSK3 to integrate various signaling cues that dictate cellular responses.

GSK3 has associations with neurodegenerative diseases and diabetes. In Alzheimer's disease GSK3 is linked to the formation of tau protein tangles contributing to neuronal dysfunction. Moreover in the context of diabetes GSK3 is involved in the insulin signaling pathway where dysregulation can lead to insulin resistance. It interacts with proteins such as tau in neurodegeneration and insulin receptor substrates in diabetes showing its significant role in these pathological conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), CTNNB1/beta-catenin, APC and AXIN1 (PubMed : 11749387, PubMed : 17478001, PubMed : 19366350). Requires primed phosphorylation of the majority of its substrates (PubMed : 11749387, PubMed : 17478001, PubMed : 19366350). Contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis (PubMed : 11749387, PubMed : 17478001, PubMed : 19366350). Regulates glycogen metabolism in liver, but not in muscle (By similarity). May also mediate the development of insulin resistance by regulating activation of transcription factors (PubMed : 10868943, PubMed : 17478001). In Wnt signaling, regulates the level and transcriptional activity of nuclear CTNNB1/beta-catenin (PubMed : 17229088). Facilitates amyloid precursor protein (APP) processing and the generation of APP-derived amyloid plaques found in Alzheimer disease (PubMed : 12761548). May be involved in the regulation of replication in pancreatic beta-cells (By similarity). Is necessary for the establishment of neuronal polarity and axon outgrowth (By similarity). Through phosphorylation of the anti-apoptotic protein MCL1, may control cell apoptosis in response to growth factors deprivation (By similarity). Acts as a regulator of autophagy by mediating phosphorylation of KAT5/TIP60 under starvation conditions which activates KAT5/TIP60 acetyltransferase activity and promotes acetylation of key autophagy regulators, such as ULK1 and RUBCNL/Pacer (PubMed : 30704899). Negatively regulates extrinsic apoptotic signaling pathway via death domain receptors. Promotes the formation of an anti-apoptotic complex, made of DDX3X, BRIC2 and GSK3B, at death receptors, including TNFRSF10B. The anti-apoptotic function is most effective with weak apoptotic signals and can be overcome by stronger stimulation (By similarity). Phosphorylates mTORC2 complex component RICTOR at 'Thr-1695' which facilitates FBXW7-mediated ubiquitination and subsequent degradation of RICTOR (PubMed : 25897075).
See full target information Glycogen synthase kinase-3 alpha phospho Y216

Additional targets

Glycogen synthase kinase-3 beta phospho Y279

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Redox biology 50:102243 PubMed35074541

2022

ER-stress promotes VHL-independent degradation of hypoxia-inducible factors via FBXW1A/βTrCP.

Applications

Unspecified application

Species

Unspecified reactive species

Daniela Mennerich,Kateryna Kubaichuk,Ghulam S Raza,Dominik C Fuhrmann,Karl-Heinz Herzig,Bernhard Brüne,Thomas Kietzmann

Cell reports 30:2332-2348.e10 PubMed32075767

2020

Defective Mitochondrial Pyruvate Flux Affects Cell Bioenergetics in Alzheimer's Disease-Related Models.

Applications

Unspecified application

Species

Unspecified reactive species

Alice Rossi,Giulia Rigotto,Giulia Valente,Valentina Giorgio,Emy Basso,Riccardo Filadi,Paola Pizzo

PLoS genetics 13:e1006922 PubMed28732025

2017

Hand factor ablation causes defective left ventricular chamber development and compromised adult cardiac function.

Applications

Unspecified application

Species

Unspecified reactive species

Joshua W Vincentz,Kevin P Toolan,Wenjun Zhang,Anthony B Firulli

Physiological reports 3: PubMed26564064

2015

Role of the Na+/H+ exchanger 3 in angiotensin II-induced hypertension in NHE3-deficient mice with transgenic rescue of NHE3 in small intestines.

Applications

WB

Species

Unspecified reactive species

Xiao C Li,Gary E Shull,Elisa Miguel-Qin,Fang Chen,Jia L Zhuo

Physiological genomics 47:479-87 PubMed26242933

2015

Role of the Na+/H+ exchanger 3 in angiotensin II-induced hypertension.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao C Li,Gary E Shull,Elisa Miguel-Qin,Jia L Zhuo

Acta neuropathologica communications 1:75 PubMed24252187

2013

Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation.

Applications

WB

Species

Mouse

Ayman ElAli,Peter Thériault,Paul Préfontaine,Serge Rivest

Diabetes 62:4088-97 PubMed23974919

2013

Gestational diabetes mellitus impairs Nrf2-mediated adaptive antioxidant defenses and redox signaling in fetal endothelial cells in utero.

Applications

Unspecified application

Species

Unspecified reactive species

Xinghua Cheng,Sarah J Chapple,Bijal Patel,William Puszyk,David Sugden,Xiaoke Yin,Manuel Mayr,Richard C M Siow,Giovanni E Mann

The Journal of pharmacology and experimental thera 334:467-76 PubMed20460386

2010

Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein.

Applications

WB

Species

Rat

A M S Hartz,E K Madole,D S Miller,B Bauer

Brain research 1332:100-9 PubMed20347724

2010

Diabetes induces changes in ILK, PINCH and components of related pathways in the spinal cord of rats.

Applications

WB

Species

Rat

Y Jiang,A P Mizisin,A Rearden,C G Jolivalt

Biochemical and biophysical research communications 319:993-1000 PubMed15184080

2004

The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.

Applications

Unspecified application

Species

Human

Anne Jämsä,Kristina Hasslund,Richard F Cowburn,Anders Bäckström,Mervi Vasänge
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com